Kevin Kos

831 total citations
8 papers, 332 citations indexed

About

Kevin Kos is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Kevin Kos has authored 8 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Kevin Kos's work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Kevin Kos is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Kevin Kos collaborates with scholars based in Netherlands, United Kingdom and United States. Kevin Kos's co-authors include Karin E. de Visser, Cheei‐Sing Hau, Bastiaan P. Krom, Mary Ann Jabra‐Rizk, Kim Vrijland, Carola H. Ries, Camilla Salvagno, Antoinette van Weverwijk, Philippe A. Cassier and Seth B. Coffelt and has published in prestigious journals such as Nature Cell Biology, Cell Reports and Gut Microbes.

In The Last Decade

Kevin Kos

8 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Kos Netherlands	8	209	184	87	34	28	8	332
Janina Schoen Germany	9	201 1.0×	44 0.2×	105 1.2×	26 0.8×	19 0.7×	12	325
Agnes Ling Sweden	10	138 0.7×	231 1.3×	108 1.2×	15 0.4×	55 2.0×	12	350
Gwennaëlle Monnot Switzerland	7	231 1.1×	110 0.6×	195 2.2×	27 0.8×	160 5.7×	8	447
Riley D. Metcalfe Australia	7	97 0.5×	103 0.6×	89 1.0×	4 0.1×	17 0.6×	12	256
Mushfiq Hassan Shaikh Canada	12	54 0.3×	123 0.7×	133 1.5×	43 1.3×	69 2.5×	32	378
Jinling Huang China	6	221 1.1×	67 0.4×	51 0.6×	4 0.1×	14 0.5×	7	321
Angelina De Martin Switzerland	9	162 0.8×	66 0.4×	78 0.9×	8 0.2×	10 0.4×	13	261
Dujo Kovačević Croatia	7	36 0.2×	70 0.4×	66 0.8×	35 1.0×	22 0.8×	16	190
Xiaomeng Wang China	8	130 0.6×	97 0.5×	157 1.8×	3 0.1×	60 2.1×	12	278
Junda M. Kel Netherlands	10	367 1.8×	42 0.2×	90 1.0×	5 0.1×	22 0.8×	11	459

Countries citing papers authored by Kevin Kos

Since Specialization

Citations

This map shows the geographic impact of Kevin Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kos more than expected).

Fields of papers citing papers by Kevin Kos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kos. The network helps show where Kevin Kos may publish in the future.

Co-authorship network of co-authors of Kevin Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kos. A scholar is included among the top collaborators of Kevin Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kos. Kevin Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Blomberg, Olga, Kevin Kos, Lorenzo Spagnuolo, et al.. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic T _reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. OncoImmunology. 12(1). 2201147–2201147. 11 indexed citations

2.

Kos, Kevin, Muhammad Assad Aslam, Rieneke van de Ven, et al.. (2022). Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Reports. 38(9). 110447–110447. 39 indexed citations

3.

Pieters, Wietske, Floor Hugenholtz, Kevin Kos, et al.. (2022). Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model. Gut Microbes. 14(1). 2035660–2035660. 7 indexed citations

4.

Kos, Kevin, Camilla Salvagno, Max D. Wellenstein, et al.. (2022). Tumor-associated macrophages promote intratumoral conversion of conventional CD4 ⁺ T cells into regulatory T cells via PD-1 signalling. OncoImmunology. 11(1). 2063225–2063225. 23 indexed citations

5.

Kos, Kevin & Karin E. de Visser. (2020). The Multifaceted Role of Regulatory T Cells in Breast Cancer. PubMed. 5(1). 291–310. 36 indexed citations

6.

Salvagno, Camilla, Metamia Ciampricotti, Cheei‐Sing Hau, et al.. (2019). Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. Nature Cell Biology. 21(4). 511–521. 122 indexed citations

7.

Putz, Eva Maria, Camille Guillerey, Kevin Kos, et al.. (2017). Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis. OncoImmunology. 6(2). e1267892–e1267892. 48 indexed citations

8.

Kos, Kevin, et al.. (2016). Candida albicansin oral biofilms could prevent caries. Pathogens and Disease. 74(5). ftw039–ftw039. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact